Erbitux for advanced colorectal cancerBristol-Myers Squibb is introducing Erbitux, a recombinant monoclonal antibody used for colorectal and head/neck cancers. Therapy hastens healing of severe Crohn’s lesions Conflict-of-interest regulation bad for research Researchers may wonder if they can measure up to application and reporting standards. They may conclude they can’t NBMS hush about contract talks Billing number restrictions continue to vex doctor supply: president Weight-loss surgery linked to bone loss Vigilance for nutritional deficiencies before and after bariatric surgery is crucial Enzymes offer promise as targets for treating progressive MS The locomotor system: Brush up on shoulder disorder diagnoses This article is a continuation of our clinical review of the locomotor system, which began in the Sept. 9 issue of the Medical Post. Hanson wins WMA presidency for 2009/10 MDs flocking to advanced business training programs Many programs offered across the country, including MBAs Alzheimer’s drug targeting beta amyloid fails in phase III trial First Previous 2483 2484 2485 2486 2487 Next Last
